You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Low energy ventricular defibrillator

    SBC: CARDIALEN, INC.            Topic: NHLBI

    DESCRIPTION (provided by applicant): Sudden cardiac death is a major cause of death around the world, with approximately 400,000 sudden deaths per year in the United States, more than are attributed to lung cancer, breast cancer, or AIDS. It is often caused by ventricular fibrillation (VF) and ventricular tachycardia (VT). VF is the most frequent mechanism of sudden death. Implantable cardiac defi ...

    STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  2. Optical Frequency Comb-Based 10 GHz Microwave Oscillators

    SBC: N.P. PHOTONICS, INC.            Topic: SB121001

    Low phase noise microwave oscillator based on the phase-coherent division of the optical signal are very compelling tool for many scientific applications such as high bandwidth precise timing distribution and synchronization, novel imaging techniques, precision metrology and spectroscopy, and radar system. This is because of the low absorption and scattering in the optical domain. The microwave ge ...

    SBIR Phase I 2012 Department of DefenseDefense Advanced Research Projects Agency
  3. Biometrics-at-a-distance

    SBC: VAWD APPLIED SCIENCE & TECHNOLOGY CORP            Topic: SB121004

    VAWD Applied Science and Technology is pleased to offer the following proposal in response to DARPA"s Small Business Initiative SB121-004, Biometrics-at-a-Distance. VAWD"s experience with development and testing of stand-off range Sense-Through-the-Wall (STTW) and Foliage Penetration (FOPEN) radars for detection and tracking of human motion in last five years enable VAWD to propose the following ...

    SBIR Phase I 2012 Department of DefenseDefense Advanced Research Projects Agency
  4. Development of novel assays for measuring concentration and metabolism of Tau in

    SBC: C2N DIAGNOSTICS LLC            Topic: NIA

    DESCRIPTION (provided by applicant): Recently, Drs. Randall Bateman and David Holtzman at the Washington University School of Medicine developed a novel stable isotope labeling kinetics (SILK) methodology for measuring the metabolism of amyloid beta (AB) in the human central nervous system (CNS). This methodology measures the ratio of labeled to unlabeled AB at multiple time points after subject i ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  5. Novel Tetravalent Vaccines for Dengue Virus

    SBC: ALTRAVAX, INC            Topic: NIAID

    DESCRIPTION (provided by applicant): Dengue virus infection is an emerging disease and an expanding global health problem. More than one-third of the world's population is at risk for transmission in tropical and subtropical areas and vaccines are an urgent public health priority. Although dengue rarely occurs in the continental United States, it is endemic in Puerto Rico, and in many popular ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  6. Germline-Specific Immunogens for the Induction of Neutralizing Antibodies to HIV-

    SBC: ALTRAVAX, INC            Topic: NIAID

    DESCRIPTION (provided by applicant): Vaccines are urgently needed to slow the spread of the HIV/AIDS epidemic, and immunogens that can induce neutralizing antibodies remain an important goal of vaccine research. An increasing number of human monoclonal antibodies (mAbs) have been isolated in recent years from individuals who show remarkably broad and potent neutralizing responses. Coupled with pas ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  7. Novel Therapeutic Vaccines for Chronic HBV

    SBC: ALTRAVAX, INC            Topic: NIAID

    DESCRIPTION (provided by applicant): Hepatitis B virus (HBV) is a noncytopathic, hepatotropic DNA virus that results in a self-limited acute infection in a majority of otherwise healthy individuals but can also cause chronic infection, particularly in newborns infected by vertical transmission. Chronic hepatitis B infection is a significant global health issue directly affecting 350 million people ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  8. Inducing Tolerance to Enzyme Replacement Therapy for Pompe Disease

    SBC: EPIVAX, INC.            Topic: NIAID

    DESCRIPTION (provided by applicant): Inducing Tolerance to Enzyme Replacement Therapy for Pompe Disease Pompe disease is a lysosomal storage disorder caused by defects in the enzyme acid alpha-glucosidase (GAA) that leads to glycogen accumulation affectingheart and skeletal muscle. Enzyme-replacement therapy with recombinant human (rh)GAA saves the lives of children with Pompe disease. The prognos ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  9. Therapeutic antibody to radiation inducible TIP1 activates immune effector cells

    SBC: RADTARGX THERAPEUTICS, INC.            Topic: NCI

    DESCRIPTION (provided by applicant): The overall objective of this research is to test the hypothesis that monoclonal antibodies to radiation-induced tumor neoantigens cause therapeutically beneficial immune responses in cancer models. We will study the efficacy of a mouse monoclonal antibody to a radiation-inducible neoantigen and analyze immune effector cell activation to control cancer. This st ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  10. Control Your Cravings: A Web-Based Transdiagnostic Self-Management Program

    SBC: GOALISTICS LLC            Topic: NIDA

    DESCRIPTION (provided by applicant): Craving, when viewed as a compelling desire to consume a potentially harmful substance or to engage in a potentially harmful act, has been increasingly targeted for basic research, clinical assessment, and treatment. The management of cravings is a critical component of treatment for self- regulatory problems such as substance and alcohol abuse, overeating, gam ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government